Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ferrous glycine sulfate adverse reaction |
Causative agent (attribute) |
True |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ferrous glycine sulphate allergy |
Causative agent (attribute) |
False |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous glycine sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ferrocontin Continus 562.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous glycine sulfate 562.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous glycine sulfate syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous glycine sulfate 562.5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous glycine sulphate allergy |
Causative agent (attribute) |
True |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ferrous glycine sulfate 562.5mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ferrous glycine sulfate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous glycine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |